During the past decade, Meridien Research conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 42 clinical trials were completed, i.e. on average, 144.8% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 25 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meridien Research" #1 sponsor was "Pfizer" with 8 trials, followed by "Cerecin" with 4 trials sponsored, "Allergan" with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Emotional Brain NY Inc." with 3 trials sponsored. Other sponsors include 59 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meridien Research" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator and "Allergan Sales, LLC" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Meridien Research" are "Alzheimer's Disease" (13 trials), "Acne Vulgaris" (3 trials), "Alzheimer Disease" (3 trials), "Cardiovascular Disease" (3 trials) and "Contraception" (3 trials). Many other conditions were trialed in "Meridien Research" in a lesser frequency.

Most popular intervention types in "Meridien Research" are "Drug" (79 trials), "Other" (6 trials), "Biological" (5 trials), "Dietary Supplement" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "PRX-03140" (3 trials), "placebo" (3 trials), "Androxal" (2 trials) and "Atogepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Meridien Research" are 67 trials for "All" genders, 12 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Meridien Research". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in Meridien Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Meridien Research, 0 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".